These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. [Identification of neuroleptics by using the characteristics of the spatial organization of the EEG]. Monakhov KK; Bochkarev VK; Paniushkina SV Farmakol Toksikol; 1986; 49(3):27-32. PubMed ID: 2873053 [TBL] [Abstract][Full Text] [Related]
45. Lithium and neuroleptic drug combination: lack of an effect on blood glucose. King DJ Br J Clin Pharmacol; 1978 Nov; 6(5):436-7. PubMed ID: 31896 [No Abstract] [Full Text] [Related]
46. Current concepts. Psychopharmacology in children. Biederman J; Jellinek MS N Engl J Med; 1984 Apr; 310(15):968-72. PubMed ID: 6142421 [No Abstract] [Full Text] [Related]
47. [TRIAL SYSTEMATIZATION OF NEUROLEPTIC COMBINATIONS]. LAMBERT PA Encephale; 1964; 53():SUPPL:262-75. PubMed ID: 14161540 [No Abstract] [Full Text] [Related]
48. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial. Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740 [TBL] [Abstract][Full Text] [Related]
49. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Möller HJ; Riedel M; Jäger M; Wickelmaier F; Maier W; Kühn KU; Buchkremer G; Heuser I; Klosterkötter J; Gastpar M; Braus DF; Schlösser R; Schneider F; Ohmann C; Riesbeck M; Gaebel W Int J Neuropsychopharmacol; 2008 Nov; 11(7):985-97. PubMed ID: 18466670 [TBL] [Abstract][Full Text] [Related]
50. Low-dose neuroleptic therapy for children with childhood-onset pervasive developmental disorder. Joshi PT; Capozzoli JA; Coyle JT Am J Psychiatry; 1988 Mar; 145(3):335-8. PubMed ID: 3344846 [TBL] [Abstract][Full Text] [Related]
51. Pharmacotherapy of irritability in pervasive developmental disorders. Stigler KA; McDougle CJ Child Adolesc Psychiatr Clin N Am; 2008 Oct; 17(4):739-52, vii-viii. PubMed ID: 18775367 [TBL] [Abstract][Full Text] [Related]
52. Safety of the combination of lithium and neuroleptic drugs. Goldney RD; Spence ND Am J Psychiatry; 1986 Jul; 143(7):882-4. PubMed ID: 2872825 [TBL] [Abstract][Full Text] [Related]
53. Motility, Parkinsonism, and prolactin with thiothixene and thioridazine. Crowley TJ; Hydinger-Macdonald M Arch Gen Psychiatry; 1981 Jun; 38(6):668-75. PubMed ID: 7247630 [TBL] [Abstract][Full Text] [Related]
55. Role of risperidone in children with autism spectrum disorder. Chavez B; Chavez-Brown M; Rey JA Ann Pharmacother; 2006 May; 40(5):909-16. PubMed ID: 16684811 [TBL] [Abstract][Full Text] [Related]
56. Antipsychotic medications: clinical use and effectiveness. Cordoba OA Hosp Pract (Off Ed); 1981 Dec; 16(12):99-101, 104, 108. PubMed ID: 6118323 [No Abstract] [Full Text] [Related]
57. Psychotic patients who become worse on neuroleptics. Bowers MB; Swigar ME J Clin Psychopharmacol; 1988 Dec; 8(6):417-21. PubMed ID: 2906948 [TBL] [Abstract][Full Text] [Related]
58. A randomised controlled trial of prophylactic neuroleptic treatment. Crow TJ; MacMillan JF; Johnson AL; Johnstone EC Br J Psychiatry; 1986 Feb; 148():120-7. PubMed ID: 2870753 [TBL] [Abstract][Full Text] [Related]
59. A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS. Bjerkenstedt L; Härnryd C; Grimm V; Gullberg B; Sedvall G Arch Psychiatr Nervenkr (1970); 1978 Dec; 226(3):157-72. PubMed ID: 32861 [TBL] [Abstract][Full Text] [Related]
60. Blood levels of neuroleptics: state of the art. Simpson GM; Yadalam K J Clin Psychiatry; 1985 May; 46(5 Pt 2):22-8. PubMed ID: 2859277 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]